Role of GABA in anxiety and depression.
This review assesses the parallel data on the role of gamma-aminobutyric acid (GABA) in depression and anxiety. We review historical and new data from both animal and human experimentation which have helped define the key role for this transmitter in both these mental pathologies. By exploring the overlap in these conditions in terms of GABAergic neurochemistry, neurogenetics, brain circuitry, and pharmacology, we develop a theory that the two conditions are intrinsically interrelated. The role of GABAergic agents in demonstrating this interrelationship and in pointing the way to future research is discussed.
Kalueff
Allan V
AV
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland, USA.
Nutt
David J
DJ
D000818:Animals; D001008:Anxiety Disorders / Q000503:physiopathology* / Q000523:psychology; D001921:Brain / Q000503:physiopathology; D003866:Depressive Disorder / Q000503:physiopathology* / Q000523:psychology; D003952:Diagnostic Imaging; D004195:Disease Models, Animal; D006801:Humans; D011963:Receptors, GABA-A / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid